Clinical implications of extended-spectrum β-lactamase-producing Klebsiella pneumoniae bacteraemia
- 1 October 2002
- journal article
- Published by Elsevier in Journal of Hospital Infection
- Vol. 52 (2) , 99-106
- https://doi.org/10.1053/jhin.2002.1288
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Extended-spectrum β-lactamasesSeminars in Respiratory Infections, 2000
- Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs)Clinical Microbiology & Infection, 2000
- Editorial Response: Extended-Spectrum -Lactamases: A Call for Improved Detection and ControlClinical Infectious Diseases, 1999
- Multiple Antibiotic–Resistant Klebsiella and Escherichia coli in Nursing HomesJAMA, 1999
- The molecular and clinical epidemiology of enterobacteriaceae-producing extended-spectrum β-lactamase in a tertiary care hospitalJournal of Infection, 1998
- Epidemiology and Successful Control of a Large Outbreak Due to Klebsiella pneumoniae Producing ExtendedSpectrum β-LactamasesAntimicrobial Agents and Chemotherapy, 1998
- EXTENDED-SPECTRUM β-LACTAMASES AND OTHER ENZYMES PROVIDING RESISTANCE TO OXYIMINO-β-LACTAMSInfectious Disease Clinics of North America, 1997
- Ceftazidime-Resistant Klebsiella pneumoniae and Escherichia coli Bloodstream Infection: A Case-Control and Molecular Epidemiologic InvestigationThe Journal of Infectious Diseases, 1996
- Outbreak of Multiply Resistant Enterobacteriaceae in an Intensive Care Unit: Epidemiology and Risk Factors for AcquisitionClinical Infectious Diseases, 1996
- Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation CephalosporinsAnnals of Internal Medicine, 1993